In a nutshell The authors aimed to determine whether dacarbazine was better as a single or combination therapy when treating malignant melanoma. Some background Dacarbazine (DTIC) has been the most used and effective treatment option in malignant melanoma, however it has a low response rate (reduction in the signs or symptoms of cancer) of...
Read More
In a nutshell The aim of this analysis was to determine the prognostic factors that can lead to the best results of Interferon treatment (as IFN or PEG-IFN) on patients with high-risk melanoma. The results indicate that tumor stage and ulceration were predictive factors for the efficacy of IFN/PEG-IFN therapy. Some background Malignant melanoma is...
Read More
In a nutshell This paper evaluated the proper frequency of follow up visits for patients treated for localized (stage I or II) melanoma. Some background Stage I and II melanomas are localized (confined) to the skin. Patients with stage I or II melanoma are generally treated with a wide excision (surgery to remove the melanoma as well as a...
Read More
